Skip to main content
PBH logo

PBH · Prestige Consumer Healthcare Inc. · Earnings Call Transcripts & Audio

Track PBH — free
$45.79 -0.08 (-0.17%)
Market Cap
$2.21B
Shares
47.37M
Volume · Oct 1 25.78K Avg daily vol (3M) 539.89K

Prestige Consumer Healthcare Inc. Earnings Call Transcripts

Quarterly earnings calls for Prestige Consumer Healthcare Inc. (PBH), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Conference
Investor event
2026-08-12
Prestige Consumer Healthcare Inc. (PBH) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-12
Prestige Consumer Healthcare Inc. (PBH) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY27 · Q1
2026-08-06
Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript
Confident tone Acquisitions (Breathe Right and Locorium Health) ClearEyes recovery and Pillar 5 facility Capital allocation and free cash flow
Revenue
$265.71M
▲ 6.5% YoY
Diluted EPS
$0.61
▼ 35.8% YoY
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Prestige Consumer Healthcare Inc. (PBH) June 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-08
Prestige Consumer Healthcare Inc. (PBH) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q4
2026-05-14
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript
Positive tone Fiscal 26 results ClearEyes / iCare supply chain recovery Pending M&A - Breathe Right and LeClorian
Revenue
$281.62M*
▼ 5% YoY
Gross margin
51.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-02-05
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Positive tone ClearEyes supply recovery Capital allocation and shareholder returns Diverse business model and channel mix
Revenue
$283.44M
▼ 2.4% YoY
Diluted EPS
$0.97
▼ 20.5% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-06
Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript
Positive tone Clear Eyes supply constraints and recovery DenTek brand and dental guards Gross margin and tariffs
Revenue
$274.11M
▼ 3.4% YoY
Diluted EPS
$0.86
▼ 21.1% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-08-07
Prestige Consumer Healthcare Inc. (PBH) Q1 2026 Earnings Call Transcript
Cautious tone Clear Eyes / Eye Care Supply Shortfall Pillar5 Acquisition Q1 Financial Results
Revenue
$249.53M
▼ 6.6% YoY
Diluted EPS
$0.95
▼ 3.1% YoY
Gross margin
56.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-05-08
Prestige Consumer Healthcare Inc. (PBH) Q4 2025 Earnings Call Transcript
Positive tone Capital allocation and leverage Innovation pipeline Marketing agility and brand portfolio
Revenue
$296.52M*
▲ 7% YoY
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-02-06
Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript
Confident tone Capital allocation and balance sheet GI category growth (Dramamine, Fleet, Gaviscon) Clear Eyes supply chain constraints recovery
Revenue
$290.32M
▲ 2.7% YoY
Diluted EPS
$1.22
▲ 15.1% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-07
Prestige Consumer Healthcare Inc. (PBH) Q2 2025 Earnings Call Transcript
Positive tone Capital allocation and leverage Canadian portfolio Gross margin and inflation
Revenue
$283.79M
▼ 0.9% YoY
Diluted EPS
$1.09
▲ 1.9% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-08-08
Prestige Consumer Healthcare Inc. (PBH) Q1 2025 Earnings Call Transcript
Positive tone Supply chain and Clear Eyes disruption Hydralyte international growth Gross margin and cost pressure
Revenue
$267.14M
▼ 4.4% YoY
Diluted EPS
$0.98
▼ 7.5% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-05-14
Prestige Consumer Healthcare Inc. (PBH) Q4 2024 Earnings Call Transcript
Cautious tone Supply chain disruptions Capital allocation and balance sheet Manufacturing and supply chain continuity
Revenue
$276.99M*
▼ 3.1% YoY
Gross margin
54.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-02-08
Prestige Consumer Healthcare Inc. (PBH) Q3 2024 Earnings Call Transcript
Confident tone Leverage and Debt Reduction Ear & Eye Care Category Growth Gross Margin and Cost Management
Revenue
$282.74M
▲ 2.6% YoY
Diluted EPS
$1.06
▲ 1.9% YoY
Gross margin
55.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2023-11-02
Prestige Consumer Healthcare Inc. (PBH) Q2 2024 Earnings Call Transcript
Revenue
$286.32M
▼ 1% YoY
Diluted EPS
$1.07
▲ 4.9% YoY
Gross margin
55.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-08-03
Prestige Consumer Healthcare Inc. (PBH) Q1 2024 Earnings Call Transcript
Revenue
$279.31M
▲ 0.8% YoY
Diluted EPS
$1.06
▼ 2.8% YoY
Gross margin
55.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-05-04
Prestige Consumer Healthcare Inc. (PBH) Q4 2023 Earnings Call Transcript
Revenue
$285.87M*
▲ 7.1% YoY
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-02-02
Prestige Consumer Healthcare Inc. (PBH) Q3 2023 Earnings Call Transcript
Revenue
$275.52M
▲ 0.4% YoY
Diluted EPS
$1.04
▲ 5.1% YoY
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-03
Prestige Consumer Healthcare Inc. (PBH) Q2 2023 Earnings Call Transcript
Revenue
$289.27M
▲ 4.7% YoY
Diluted EPS
$1.02
▲ 14.6% YoY
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-04
Prestige Consumer Healthcare Inc. (PBH) Q1 2023 Earnings Call Transcript
Revenue
$277.06M
▲ 2.9% YoY
Diluted EPS
$1.09
▼ 4.4% YoY
Gross margin
57.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-05-05
Prestige Consumer Healthcare Inc. (PBH) Q4 2022 Earnings Call Transcript
Revenue
$266.94M*
▲ 12.3% YoY
Gross margin
55.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-03
Prestige Consumer Healthcare Inc. (PBH) Q3 2022 Earnings Call Transcript
Revenue
$274.47M
▲ 14.9% YoY
Diluted EPS
$0.99
▲ 22.2% YoY
Gross margin
56.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-04
Prestige Consumer Healthcare Inc. (PBH) Q2 2022 Earnings Call Transcript
Revenue
$276.23M
▲ 16.3% YoY
Diluted EPS
$0.89
▲ 1.1% YoY
Gross margin
57.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-05
Prestige Consumer Healthcare Inc. (PBH) Q1 2022 Earnings Call Transcript
Revenue
$269.18M
▲ 17.3% YoY
Diluted EPS
$1.14
▲ 32.6% YoY
Gross margin
59.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-05-06
Prestige Consumer Healthcare Inc. (PBH) Q4 2021 Earnings Call Transcript
Revenue
$237.76M*
▼ 5.4% YoY
Gross margin
57.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-04
Prestige Consumer Healthcare Inc. (PBH) Q3 2021 Earnings Call Transcript
Revenue
$238.79M
▼ 1.1% YoY
Diluted EPS
$0.81
▲ 8% YoY
Gross margin
58.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-11-05
Prestige Consumer Healthcare Inc. (PBH) Q2 2021 Earnings Call Transcript
Revenue
$237.42M
▼ 0.3% YoY
Diluted EPS
$0.88
▲ 35.4% YoY
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-08-06
Prestige Consumer Healthcare Inc. (PBH) Q1 2021 Earnings Call Transcript
Revenue
$229.39M
▼ 1.2% YoY
Diluted EPS
$0.86
▲ 32.3% YoY
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-05-07
Prestige Consumer Healthcare Inc. (PBH) Q4 2020 Earnings Call Transcript
Revenue
$251.24M
▲ 4.2% YoY
Diluted EPS
$0.73
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-02-06
Prestige Consumer Healthcare Inc. (PBH) Q3 2020 Earnings Call Transcript
Revenue
$241.55M
▲ 0.1% YoY
Diluted EPS
$0.75
▲ 2.7% YoY
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-06-30
Prestige Consumer Healthcare Inc. (PBH) Q1 2020 Earnings Call Transcript
Revenue
$232.15M
▼ 8.6% YoY
Diluted EPS
$0.65
▲ 0% YoY
Gross margin
57.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–32 of 32 earnings calls
Key facts CIK 1295947 CUSIP 74112D101 13F (30d) 11 filings 9 filers Visit website Investor relations